Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ipilimumab (yervoy) (1 trial)
sipuleucel-t (Provenge) (1 trial)
Prostatic Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (2 total)